首页 | 本学科首页   官方微博 | 高级检索  
     


Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men
Authors:Frans M.J. Debruyne  Hermann M. Behre  Claus G. Roehrborn  Mario Maggi  Frederick C.W. Wu  Fritz H. Schröder  Thomas Hugh Jones  Hartmut Porst  Geoffrey Hackett  Olivia A. Wheaton  Antonio Martin‐Morales  Eric Meuleman  Glenn R. Cunningham  Hozefa A. Divan  Raymond C. Rosen  the RHYME Investigators
Affiliation:1. Andros Men's Health Institutes, Arnhem, The Netherlands;2. Center for Reproductive Medicine and Andrology, Martin Luther University Halle‐Wittenberg, Halle, Germany;3. Southwestern Medical Center, University of Texas, Dallas, TX, USA;4. Sexual Medicine and Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy;5. University of Manchester, Manchester, UK;6. Erasmus Medical Center, Rotterdam, The Netherlands;7. Barnsley Hospital NHS Foundation Trust, Barnsley, UK;8. Private Practice of Urology/Andrology, Hamburg, Germany;9. Holly Cottage Clinic, Lichfield, Staffordshire, UK;10. New England Research Institutes, Inc., Watertown, MA, USA;11. Carlos Haya University Hospital, Málaga, Spain;12. VU Medical Center, Amsterdam, The Netherlands;13. Baylor College of Medicine, St. Luke's Episcopal Hospital, Houston, TX, USA
Abstract:
Keywords:testosterone  hypogonadism  disease registry  benign prostatic hyperplasia  #ProstateCancer  #PCSM
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号